医療機器再処理市場：タイプ（再処理された医療機器）、機器カテゴリ（重要機器、準重要機器、非重要機器）、用途（循環器、婦人科、消化器、麻酔）別 - 2027年までの世界予測

Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027

医療機器再処理市場は、2022年の20億米ドルから2027年には39億米ドルに達すると予測され、予測期間中のCAGRは13.7%となります。市場の成長は主に、病院費用を最小限に抑えるニーズの高まりと、高齢者人口の増加、... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年7月28日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	173	151	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

医療機器再処理市場は、2022年の20億米ドルから2027年には39億米ドルに達すると予測され、予測期間中のCAGRは13.7%となります。市場の成長は主に、病院費用を最小限に抑えるニーズの高まりと、高齢者人口の増加、およびシングルユースの再処理医療機器の再利用に対する有利な規制上の承認によってもたらされています。しかし、医療機器再処理市場に参入するためには、厳しい規制手続きに従わなければならないため、市場成長の脅威となる可能性があります。

タイプ別では、リプロセシングサポート＆サービス部門が2021年に最大の市場シェアを占める
医療機器リプロセシング市場は、タイプ別にリプロセシングサポート＆サービスとリプロセシング医療機器に区分される。2021年には、主に医療廃棄物を減らすための戦略を実行する必要性が高まっていることから、リプロセシングサポート＆サービス分野が最大のシェアを占めています。

デバイスタイプ別では、クリティカルデバイス部門が医療機器リプロセス市場で最大のシェアを占める
医療機器リプロセシング市場は、デバイスタイプに基づき、クリティカルデバイス、セミクリティカルデバイス、ノンクリティカルデバイスに区分される。2021年には、クリティカルデバイスのセグメントがこの市場の最大のシェアを占めています。このセグメントの成長は、主に心臓手術や電気生理学的処置のために再処理された医療機器の利用が増加したことに起因しています。

用途別では、心臓病学分野が予測期間中に最も高いCAGRを示すと予想されます。
医療機器の再処理市場は、用途別に、心臓病学、消化器病学、婦人科、関節鏡および整形外科、一般外科および麻酔、その他の用途（泌尿器、非侵襲性外科、患者モニタリング）に区分されます。予測期間中は、心臓病学分野が最も高い成長を記録すると予想されます。これは、心血管疾患の有病率の増加や、大量の再処理された心臓カテーテルやその他の機器を使用する心臓手術の増加に起因しています。

2021年の医療機器再処理市場は、北米が最大のシェアを占めています。
2021年の医療機器再処理市場は、北米が最大のシェアを占めています。米国における医療費削減ニーズの高まりや、米国地域におけるトップクラスの医療機器再処理サービスプロバイダーの存在などの要因が、北米の医療機器再処理市場の成長に寄与すると予想されます。

主な参加企業の内訳は、以下の通りです。
- 企業タイプ別 - Tier1-35%、Tier2-45%、Tier3-20%。
- 役職別：Cレベル-35％、ディレクターレベル-25％、その他-40
- 地域別：北米45％、欧州30％、アジア太平洋20％、中南米3％、中東・アフリカ2％。

医療機器再処理市場の主要企業
医療機器再処理市場で事業を展開する主なプレーヤーは、Stryker Corporation（米国）、Johnson & Johnson（米国）、Vanguard AG（ドイツ）、Medtronic PLC（アイルランド）、Steris Healthcare（米国）、Medline ReNewal（米国）、Innovative Health（米国）、Arjo Group (ReNu Medical, Inc.) (スウェーデン)、Technisches Inc.)（スウェーデン）、ステリプロ・カナダ, INC.（カナダ）、Northeast Scientific, INC.（米国）、Cardinal Health (Sustainable Technologies) （米国）、SureTek Medical（米国）、Konoike Group（日本）、Avante Health Solutions（米国）、Medsalv（ニュージーランド）、Vitruvia Medical AG（スイス）などがあります。

調査対象範囲
このレポートは医療機器再処理市場を分析し、タイプ、デバイスタイプ、アプリケーション、地域などの様々なセグメントに基づいて、この市場の市場規模および将来の成長性を推定することを目的としています。また、市場で利用可能な様々な医療機器再処理サービスのサービスポートフォリオマトリックスも掲載しています。また、本市場の主要企業の競争力分析も行っており、企業プロファイル、サービス内容、主要な市場戦略も併せて掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができ、ひいては市場のより重要なシェアを獲得するのに役立つでしょう。本レポートを購入された企業は、以下の戦略のいずれか、または組み合わせて使用することで、市場での地位を強化することができます。

本レポートでは、以下のポイントについて考察しています。
- 市場浸透度。世界の医療機器再処理市場の上位企業が提供するサービスポートフォリオに関する包括的な情報。本レポートでは、この市場をタイプ別、デバイスタイプ別、アプリケーション別に分析しています。
- サービスの強化/FDA承認。世界の医療機器再処理市場における今後の動向とサービス承認に関する詳細な洞察。
- 市場開発。タイプ、デバイスタイプ、アプリケーション別に、有利な新興市場に関する包括的な情報を提供します。
- 市場の多様化。世界の医療機器再処理市場における新サービス、成長地域、最近の開発、投資に関する徹底的な情報
- 競争力の評価。世界の医療機器再処理市場における主要企業の市場シェア、成長戦略、サービス内容、競争上のリーダーシップマッピング、能力に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION AND SCOPE 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.2.2 MARKETS COVERED 23
FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION 23
1.2.3 YEARS CONSIDERED 23
1.3 CURRENCY CONSIDERED 24
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021 24
1.4 STAKEHOLDERS 24
1.5 SUMMARY OF CHANGES 24
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH APPROACH 26
2.2 RESEARCH METHODOLOGY DESIGN 26
FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN 26
2.2.1 SECONDARY DATA 27
2.2.1.1 Key data from secondary sources 27
2.2.2 PRIMARY DATA 28
FIGURE 3 PRIMARY SOURCES 28
2.2.2.1 Key data from primary sources 29
2.2.2.2 Insights from primary experts 30
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 30
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 31
2.3 MARKET SIZE ESTIMATION 31
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 32
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 32
FIGURE 8 TOP-DOWN APPROACH 33
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34
FIGURE 10 CAGR PROJECTIONS 35
2.4 DATA TRIANGULATION 36
FIGURE 11 DATA TRIANGULATION METHODOLOGY 36
2.5 MARKET SHARE ESTIMATION 37
2.6 RESEARCH ASSUMPTIONS 37
2.7 LIMITATIONS 37
2.7.1 METHODOLOGY-RELATED LIMITATIONS 37
2.7.2 SCOPE-RELATED LIMITATIONS 38
2.8 RISK ASSESSMENT 38
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET 38
3 EXECUTIVE SUMMARY 39
FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 39
FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2022 VS. 2027 (USD MILLION) 40
FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 40
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET 41
4 PREMIUM INSIGHTS 43
4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET 43
FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE
HEALTHCARE COSTS TO DRIVE MARKET 43
4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021) 44
FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD 44
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 45
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 45
4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020–2027) 46
FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 46
4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS 46
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing level of supply chain cost savings in healthcare facilities 48
5.2.1.2 Growing adoption of strategies for sustainability and
environmental safety 48
TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING 49
5.2.1.3 Rising geriatric population 49
FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION 50
TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS 50
5.2.2 RESTRAINTS 50
5.2.2.1 Increasing risk of hospital-acquired infections among patients 50
5.2.2.2 Increasing number of medical device surface alterations
due to reprocessing 51
TABLE 5 IMPACT ANALYSIS: RESTRAINTS 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 Regulatory changes favoring adoption of medical device reprocessing 52
5.2.3.2 Growing opportunities and favorable regulations in
developing countries 52
TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES 53
5.2.4 CHALLENGES 53
5.2.4.1 Stringent regulatory procedures for reprocessed medical devices 53
TABLE 7 IMPACT ANALYSIS: CHALLENGES 53
5.3 KEY CONFERENCES AND EVENTS 54
TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED
LIST OF CONFERENCES AND EVENTS 54
5.4 INDUSTRY TRENDS 55
5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH
THROUGH ACQUISITIONS 55
TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET 55
5.4.2 SPECIALTY REPROCESSING 55
5.5 PORTER’S FIVE FORCES ANALYSIS 56
TABLE 10 PORTER’S FIVE FORCES ANALYSIS 56
5.5.1 THREAT FROM NEW ENTRANTS 56
5.5.2 THREAT FROM SUBSTITUTES 57
5.5.3 BARGAINING POWER OF SUPPLIERS 57
5.5.4 BARGAINING POWER OF BUYERS 57
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 58
TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 58
5.7 REGULATORY ANALYSIS 59
5.7.1 NORTH AMERICA 59
5.7.1.1 US 59
FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES 59
5.7.1.2 Canada 60
5.7.2 EUROPE 60
TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING 61
5.7.3 ASIA PACIFIC 61
5.7.3.1 Japan 61
5.7.3.2 Australia 61
5.7.3.3 Rest of Asia Pacific 62
TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING 62

5.8 TECHNOLOGY ANALYSIS 62
TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE
REPROCESSING MARKET 62
5.9 SUPPLY CHAIN ANALYSIS 63
FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET 64
5.10 ECOSYSTEM ANALYSIS 64
FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS 64
5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS 65
5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING 65
FIGURE 26 PATENT PUBLICATION TRENDS (2011–JULY 2022) 65
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 65
FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011–JULY 2022) 66
FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011–JULY 2022) 67
TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021–2022 67
5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET 68
6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE 69
6.1 INTRODUCTION 70
TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 70
6.2 REPROCESSING SUPPORT AND SERVICES 70
6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET 70
TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 71
6.3 REPROCESSED MEDICAL DEVICES 71
6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER
COSTS TO DRIVE MARKET 71
TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 72
TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 74
7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE 75
7.1 INTRODUCTION 76
TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 76
7.2 CRITICAL DEVICES 76
7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET 76
TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY 77
TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 78

7.3 SEMI-CRITICAL DEVICES 78
7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET 78
TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
7.4 NON-CRITICAL DEVICES 79
7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET 79
TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 80
8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION 81
8.1 INTRODUCTION 82
TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 82
8.2 CARDIOLOGY 82
8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET 82
TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 83
8.3 GASTROENTEROLOGY 84
8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS
TO DRIVE MARKET 84
TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 84
8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY 85
8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET 85
TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING 85
TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020–2027 (USD MILLION) 86
8.5 GYNECOLOGY 86
8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET 86
TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 87
8.6 GENERAL SURGERY 87
8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET 87
TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES,
BY COUNTRY, 2020–2027 (USD MILLION) 88
8.7 OTHER APPLICATIONS 88
TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 89
9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION 90
9.1 INTRODUCTION 91
FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021) 91
TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION,
2020–2027 (USD MILLION) 92

9.2 NORTH AMERICA 92
FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT 93
TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION) 94
TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 94
TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 94
9.2.1 US 95
9.2.1.1 Presence of major players and healthcare cost reduction strategies to drive market 95
FIGURE 31 US: TOTAL NUMBER OF HOSPITALS 95
TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 96
TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 96
TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 96
9.2.2 CANADA 97
9.2.2.1 Growing geriatric population and increasing chronic diseases
to drive market 97
TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 97
TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 98
TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
9.3 EUROPE 98
TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 99
TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 100
TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100
9.3.1 GERMANY 100
9.3.1.1 Government initiatives and well-established standards to
drive market 100
TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 101
TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 101
TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 102
9.3.2 UK 102
9.3.2.1 Increasing hospital admissions to drive market 102
TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 103
TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 103
TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 103
9.3.3 FRANCE 104
9.3.3.1 Growing diagnostic medical device market with rising chronic diseases to propel market 104
TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 104
TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 105
TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
9.3.4 ITALY 105
9.3.4.1 Increasing use of diagnostic devices and government initiatives to drive market 105
TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 106
TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 106
TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 107
9.3.5 SPAIN 107
9.3.5.1 Increasing focus on reducing hospital costs to drive market 107
TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 108
TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 108
TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 108
9.3.6 REST OF EUROPE 109
TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 110
TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 110
9.4 ASIA PACIFIC 110
FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT 111
TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 112
TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET,
BY DEVICE TYPE, 2020–2027 (USD MILLION) 112
TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
9.4.1 AUSTRALIA 113
9.4.1.1 Growing adoption of medical devices for diagnosis and treatment to drive market 113
TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 114
TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 114
TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
9.4.2 JAPAN 115
9.4.2.1 Regulatory reforms and need to reduce hospital costs to drive market 115
TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 116
TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 116
9.4.3 CHINA 117
9.4.3.1 Government initiatives and developing economy to drive market 117
TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 118
TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 118
9.4.4 INDIA 118
9.4.4.1 Government initiatives for diagnosis and treatment to drive market 118
TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 119
TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE
2020–2027 (USD MILLION) 119
TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 120
9.4.5 REST OF ASIA PACIFIC 120
TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET,
BY DEVICE TYPE, 2020–2027 (USD MILLION) 121
TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 121
9.5 LATIN AMERICA 122
9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET 122
TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET,
BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 123
TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 123
9.6 MIDDLE EAST & AFRICA 124
9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET 124
TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET,
BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET,
BY DEVICE TYPE, 2020–2027 (USD MILLION) 125
TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 125
10 COMPETITIVE LANDSCAPE 126
10.1 OVERVIEW 126
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 126
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL
DEVICE REPROCESSING MARKET 126
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 127
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE
REPROCESSING MARKET 128
10.4 MARKET SHARE ANALYSIS, 2021 128
FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021 129
TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION 129
10.5 COMPETITIVE BENCHMARKING 130
TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS 130
10.6 COMPANY FOOTPRINT 131
TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET 131
TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES) 132
TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES) 133
TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES) 134
10.7 COMPANY EVALUATION QUADRANT 134
10.7.1 STARS 135
10.7.2 EMERGING LEADERS 135
10.7.3 PERVASIVE PLAYERS 135
10.7.4 PARTICIPANTS 135
FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021) 136
10.8 COMPETITIVE SCENARIO 137
10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS 137
10.8.2 DEALS 138
10.8.3 OTHER DEVELOPMENTS 138

11 COMPANY PROFILES 140
11.1 KEY PLAYERS 140
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER CORPORATION 140
TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW 140
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021) 141
11.1.2 JOHNSON & JOHNSON 143
TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW 143
FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 144
11.1.3 MEDTRONIC PLC 146
TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW 146
FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 147
11.1.4 STERIS HEALTHCARE 149
TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW 149
FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021) 150
11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES) 152
TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW 152
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 153
11.1.6 ARJO GROUP (RENU MEDICAL, INC.) 154
TABLE 105 ARJO GROUP: COMPANY OVERVIEW 154
FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021) 155
11.1.7 VANGUARD AG 156
TABLE 106 VANGUARD AG: COMPANY OVERVIEW 156
11.1.8 MEDLINE RENEWAL 157
TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW 157
11.1.9 INNOVATIVE HEALTH 159
TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW 159
11.1.10 STERIPRO CANADA, INC 161
TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW 161
11.1.11 NORTHEAST SCIENTIFIC, INC. 162
TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW 162
11.2 OTHER PLAYERS 164
11.2.1 SURETEK MEDICAL 164
11.2.2 KONOIKE GROUP 165
11.2.3 AVANTE HEALTH SOLUTIONS 166
11.2.4 MEDSALV 167
11.2.5 VITRUVIA MEDICAL AG 168
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 169
12.1 INSIGHTS FROM INDUSTRY EXPERTS 169
12.2 DISCUSSION GUIDE 170
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 174
12.4 CUSTOMIZATION OPTIONS 176
12.5 RELATED REPORTS 176
12.6 AUTHOR DETAILS 177

ページTOPに戻る

Table of Contents

Summary

The medical device reprocessing market is projected to reach USD 3.9 billion by 2027 from USD 2.0 billion in 2022, at a CAGR of 13.7% during the forecast period. Growth in the market is mainly driven by the growing need to minimize hospital costs and the rising geriatric population, and the favourable regulatory approvals for reuse of single-use reprocessed medical devices. However, the requirement to follow stringent regulatory procedures to enter the medical device reprocessing market may pose a threat to the market growth.

Based on type, the reprocessing support & services segment holds the largest market share in 2021
Based on type, the medical device reprocessing market is segmented into reprocessing support & services and reprocessed medical devices. In 2021, the reprocessing support & services segment accounted for the largest share of this market, primarily due to the growing need implement strategies to reduce medical wastes.

Based on device type , critical devices segment accounted for the largest share of the medical device reprocessing market
Based on the device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The growth of this segment is mainly attributed to the increased utilization of reprocessed medical devices for cardiac surgeries and electrophysiology procedures.

Based on application, cardiology segment is expected to have the highest CAGR during the forecast period
Based on application, the medical device reprocessing market is segmented into cardiology, gastroenterology, gynecology, arthroscopy and orthopedic surgery, general surgery & anesthesia, and other applications (urology, non-invasive surgeries, and patient monitoring). The cardiology segment is expected to register the highest growth during the forecast period. This can be attributed to the increasing prevalence of cardiovascular diseases as well as the increasing number of cardiac procedures, which utilizes a large volume of reprocessed cardiology catheters and other equipments.

North America accounted for the largest share of the medical device reprocessing market in 2021
North America accounted for the largest share of the medical device reprocessing market in 2021. Factors such as the increasing need to reduce the healthcare costs in US, and the presence of top medical device reprocessing service providers in the US region are expected to contribute to the growth of the medical device reprocessing market in North America.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Medical Device Reprocessing Market
The key players operating in the medical device reprocessing market include Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US), SureTek Medical (US), Konoike Group (Japan), Avante Health Solutions (US), Medsalv (New Zealand), and Vitruvia Medical AG (Switzerland).

Research Coverage:
The report analyzes the medical device reprocessing market aims at estimating the market size and future growth potential of this market based on various segments such as type, device type, application, and region. The report also includes a service portfolio matrix of various medical device reprocessing services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on service portfolios offered by the top players in the global medical device reprocessing market. The report analyzes this market by type, device type, and application.
• Service Enhancement/FDA Approvals: Detailed insights on upcoming trends and service approvals in the global medical device reprocessing market
• Market Development: Comprehensive information on the lucrative emerging markets by type, device type, and application.
• Market Diversification: Exhaustive information about new services, growing geographies, recent developments, and investments in the global medical device reprocessing market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global medical device reprocessing market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cardiology）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

医療機器再処理市場：タイプ（再処理された医療機器）、機器カテゴリ（重要機器、準重要機器、非重要機器）、用途（循環器、婦人科、消化器、麻酔）別 - 2027年までの世界予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cardiology）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?